Maropitant citrate salt is a neurokinin-1 receptor antagonist primarily indicated for the prevention and treatment of vomiting and motion sickness in dogs. As an NK1 receptor antagonist, it functions by… Read more
Maropitant citrate salt is a neurokinin-1 receptor antagonist primarily indicated for the prevention and treatment of vomiting and motion sickness in dogs. As an NK1 receptor antagonist, it functions by blocking the binding of substance P in the emetic response pathway. This category provides access to high-quality reference standards for maropitant citrate, along with its associated degradation products, synthetic intermediates, and potential impurities such as (2S,3S)-2-benzhydrylquinuclidin-3-amine and (2S,3S)-2-benzhydryl-N-benzylquinuclidin-3-amine. Analytical laboratories utilize these compounds for comprehensive impurity profiling, method validation, and routine quality control processes. By incorporating these reference materials into testing protocols, researchers can ensure the accuracy of assays, confirm the identification of unknown peaks during stability studies, and maintain strict compliance with regulatory standards throughout the pharmaceutical development lifecycle.
